Diabetes is currently the 5th most common cause of death in the world.
5% of people (1 in 20) in the UK have diabetes.
Diabetes is the 7th leading cause of death in the US.
Around 1 in 8 people between 20 and 79 years old have their death attributed to diabetes.
The average life expectancy is reduced by:
More than 20 years (Type 1)
Up to 10 years (Type 2)
Tap on icon for description, click on resource name for more details.
Company that develops, manufactures and distributes continuous glucose monitoring systems for diabetes management.
Pharmaceutical company focused on the development of novel drugs for the treatment of diabetes.
Journal covering all aspects of diagnosing and managing diabetes.
Develops Engineered Micro-Pancreas (EMP) as a cell therapy solution for insulin-dependent diabetes
Regenerative medicine company dedicated to developing a functional cure for type 1 diabetes.
Nonprofit organization that funds type 1 diabetes research.
Leading charity for people living with diabetes in the UK.
Medical device company creating solutions for people with diabetes.
Insulin pump system developed by Medtronic.
Barts Health NHS Trust uses AI to find patients at-risk for diabetic foot disease
Digital Health - 20-Aug-2021
Clinithink AI helped physicians in preventing serious complications among diabetes patientsRead more...
Study finds multiple health benefits from time restricted eating (TRE)
EurekAlert! - 17-Aug-2021
Strong protection against fatty liver disease seen in mice regardless of age and sexRead more...
Patients with Type 2 diabetes are treated with their bone marrow stem cell
EurekAlert! - 03-Jun-2021
Need for stem cell intervention for patients diagnosed with T2DMRead more...
NMN improved muscle glucose uptake in prediabetic women
Medical Xpress - 22-Apr-2021
Further studies to confirm clinical benefits of this anti-aging compound in a large sampleRead more...
Summary of Dr Gervasio Lamas presentation on EDTA clinical trial
Live Forever Club - 05-Feb-2021
5-year mortality for diabetic heart attach patients reduced by 43%Read more...